Related Experiment Video
Updated: May 5, 2026

14:04
Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
17.7K
In Vivo Behavior of Biomimetic Nanoparticles: Strategies for Clearance Avoidance, Targeting, and Functional Delivery
Polina Lazareva1, Vladimir Chulanov2,3,4, Dmitry Kostyushev3,5,6
1Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, Moscow 117997, Russia.
Molecules (Basel, Switzerland)
|November 27, 2025
Summary
Biomimetic cell membrane-coated nanoparticles (BMCNPs) offer advanced drug delivery by mimicking natural cell membranes. This review details their in vivo behavior, highlighting strategies for enhanced therapeutic performance and translation.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Biomimetic cell membrane-coated nanoparticles (BMCNPs) integrate inorganic cores with natural cell membranes.
- This hybrid approach leverages nanomaterial versatility and biological system specificity.
Purpose of the Study:
- To review the in vivo behavior of BMCNPs.
- To analyze interactions with biological barriers and mononuclear phagocyte system clearance.
- To examine the influence of membrane source and surface properties on targeting and delivery.
Main Methods:
- Literature review focusing on in vivo studies of BMCNPs.
- Analysis of biodistribution, circulation kinetics, and immune evasion mechanisms.
- Evaluation of targeting efficiency based on membrane characteristics.
Main Results:
- BMCNPs demonstrate prolonged circulation and immune evasion.
- Biodistribution patterns and circulation kinetics are influenced by membrane properties.
- Surface characteristics significantly impact tissue targeting and therapeutic outcomes.
Conclusions:
- BMCNPs show significant potential as drug delivery platforms.
- Optimizing membrane source and surface properties is crucial for therapeutic efficacy.
- Further strategies are needed to enhance translational potential for clinical applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160

